Mangalam Drugs and Organics Ltd. - Research Center
532637 MANGALAM Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 169.02 | 217.82 | 214.79 | 218.98 | 200.67 |
| Operating profit | -1.28 | 18.81 | 16.47 | 15.29 | 31.24 |
| Interest | 6.66 | 6.10 | 5.22 | 5.94 | 4.76 |
| Gross profit | -7.89 | 12.72 | 19.29 | 18.69 | 27.82 |
| EPS (Rs) | -8.27 | 3.30 | 6.77 | 5.65 | 12.25 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.05 | 0.01 | 8.04 | 9.34 | 1.34 |
| Stock adjustment | -10.61 | -21.35 | -1.13 | -32.62 | -13.81 |
| Raw material | 126.56 | 155.41 | 150.78 | 188.30 | 147.78 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 18.99 | 18.90 | 20.33 | 16.93 | 14.00 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 35.37 | 46.05 | 28.35 | 31.09 | 21.46 |
| Provisions made | - | - | - | - | - |
| Depreciation | 7.15 | 5.36 | 5.36 | 4.89 | 4.33 |
| Taxation | -1.94 | 2.13 | 3.22 | 4.86 | 4.11 |
| Net profit / loss | -13.10 | 5.23 | 10.71 | 8.94 | 19.38 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -0.76 | 8.63 | 7.67 | 6.98 | 15.57 |
| GPM (%) | -4.67 | 5.84 | 8.66 | 8.19 | 13.77 |
| NPM (%) | -7.75 | 2.40 | 4.81 | 3.92 | 9.60 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis